+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bleeding Disorder Diagnostics Market - Global Forecast 2026-2032- Product Image
Bleeding Disorder Diagnostics Market - Global Forecast 2026-2032- Product Image
New

Bleeding Disorder Diagnostics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 180 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5968399
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The bleeding disorder diagnostics market is evolving rapidly as healthcare systems pursue more precise, efficient, and technology-driven solutions. Senior executives must balance advancing clinical requirements with operational realities, supply chain priorities, and regulatory compliance to maintain a competitive edge.

Market Snapshot—Bleeding Disorder Diagnostics Market Size and Growth

The bleeding disorder diagnostics market expanded from USD 765.34 million in 2025 to USD 825.34 million in 2026 and is expected to grow at a CAGR of 7.90%, ultimately reaching USD 1.30 billion by 2032. Market momentum is supported by advances in molecular testing, the integration of digital health capabilities, and robust demand for precision diagnostics across established and emerging healthcare environments. Adoption is being accelerated as clinical teams require earlier identification, improved risk assessment, and patient-centric care pathways.

Scope & Segmentation

  • Product Types: Coagulometers, thromboelastography analyzers, calibrators, controls, diagnostic kits, and value-added services for ongoing maintenance or hands-on training.
  • Technology Types: Chromogenic assays, immunoassay methods, molecular diagnostics, and viscoelastic testing platforms—each providing unique operational benefits or differentiating analytical strengths.
  • End Users: Diagnostic laboratories, hospitals, and research institutes, each with specific priorities regarding throughput, workflow integration, and quality assurance.
  • Applications: Spanning early diagnosis, therapy monitoring, and comprehensive screening, supporting clinical decisions across the continuum of patient care.
  • Disease Subtypes: Hemophilia A, Hemophilia B, and Von Willebrand Disease, with each disease subtype demanding tailored testing protocols and specific operational workflows from diagnostic providers.
  • Geographical Coverage: Regions include Americas, Europe, Middle East & Africa, and Asia-Pacific, with market needs diverging based on healthcare infrastructure, procurement approaches, and system maturity. Regional market maturity also shapes adoption—emerging economies focus on robust reagents and scalable solutions, while more mature regions emphasize value assessment and advanced clinical validation.

Key Takeaways: Strategic Insights for Leaders

  • Technology convergence is shaping new standards of diagnostic precision, enabling clinical teams to identify bleeding risks sooner and offer tailored patient management.
  • Procurement decisions now depend at least as much on interoperability, service support, and total cost of ownership as on traditional performance metrics.
  • Decentralized and point-of-care testing models are gaining traction, allowing for rapid turnaround and supporting near-patient decision-making, especially in critical and acute care contexts.
  • Increased regulatory scrutiny necessitates more rigorous evidence of analytical validation and clinical utility, with payers and providers placing weight on proven outcome data.
  • Regional market dynamics influence procurement and adoption. While developing economies value supply chain stability and product robustness, established markets prioritize advanced analytics, regulatory compliance, and health-technology assessments.
  • Collaborative approaches, such as co-development agreements or integrated service offerings, are necessary to streamline market entry, support validation, and strengthen differentiation in a competitive landscape.

Tariff Impact on Procurement and Supply Chains

Tariffs implemented in 2025 resulted in widespread price increases along the diagnostics supply chain. Procurement leaders responded by re-evaluating supply strategies, focusing on agreements with built-in cost-protection and favoring localized manufacturing or strategic inventory practices. Manufacturers sought to offset tariff-induced risks through regional partnerships and by shifting production to less exposed markets. As a result, organizational focus shifted toward greater supply chain resilience, agile inventory management, and multi-sourcing strategies.

Methodology & Data Sources

This research utilizes a robust mixed-methods approach, combining in-depth interviews with laboratory directors, clinical leaders, procurement managers, and industry executives. Primary findings are validated through comprehensive secondary research spanning regulatory publications, peer-reviewed studies, and key clinical datasets to provide an informed perspective on market adoption and commercial trends.

Why This Report Matters

  • Enables evidence-based management by highlighting local and regional trends in diagnostic technology uptake, procurement evolution, and reimbursement requirements across all major geographies.
  • Supports leadership teams in anticipating changes to regulatory standards and supply chains, while refining product development strategies and prioritizing investment decisions for optimal and sustained market access.
  • Delivers actionable segmentation, empowering commercial, clinical, and strategic teams to align offerings with shifting buyer priorities and clinical needs.

Conclusion

Technology integration, clinical priorities, and procurement models are re-defining the bleeding disorder diagnostics landscape. Leaders who drive validated, integrated solutions and adapt to operational and regulatory expectations will unlock lasting competitive advantage.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Bleeding Disorder Diagnostics Market, by Product Type
8.1. Instruments
8.1.1. Coagulometers
8.1.2. Thromboelastography Analyzers
8.2. Reagents
8.2.1. Calibrators
8.2.2. Controls
8.2.3. Kits
8.3. Services
8.3.1. Maintenance
8.3.2. Training
9. Bleeding Disorder Diagnostics Market, by Technology
9.1. Chromogenic Assays
9.2. Immunoassays
9.3. Molecular Diagnostics
9.4. Viscoelastic Testing
10. Bleeding Disorder Diagnostics Market, by End User
10.1. Diagnostic Laboratories
10.2. Hospitals
10.3. Research Institutes
11. Bleeding Disorder Diagnostics Market, by Application
11.1. Diagnosis
11.2. Monitoring
11.3. Screening
12. Bleeding Disorder Diagnostics Market, by Disease Type
12.1. Hemophilia A
12.2. Hemophilia B
12.3. Von Willebrand Disease
13. Bleeding Disorder Diagnostics Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Bleeding Disorder Diagnostics Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Bleeding Disorder Diagnostics Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Bleeding Disorder Diagnostics Market
17. China Bleeding Disorder Diagnostics Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. ARUP Laboratories
18.7. Baxter International Inc.
18.8. Bayer AG
18.9. Bio-Rad Laboratories, Inc.
18.10. Cepheid by Danaher Corporation
18.11. CSL Limited
18.12. Danaher Corporation
18.13. Diagnostica Stago SAS
18.14. F. Hoffmann-La Roche AG
18.15. HORIBA, Ltd.
18.16. Hyphen BioMed by Sysmex Corporation
18.17. Laboratory Corporation of America Holdings
18.18. Novo Nordisk A/S
18.19. Ortho Clinical Diagnostics Inc.
18.20. Precision BioLogic
18.21. rHEALTH
18.22. Siemens Healthineers AG
18.23. Sysmex Corporation
18.24. Takeda Pharmaceutical Company Limited
18.25. Thermo Fisher Scientific Inc.
18.26. Werfen Life S.L.U.
List of Figures
FIGURE 1. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY COAGULOMETERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY COAGULOMETERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY COAGULOMETERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY THROMBOELASTOGRAPHY ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY THROMBOELASTOGRAPHY ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY THROMBOELASTOGRAPHY ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY CALIBRATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY CALIBRATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY CALIBRATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY CONTROLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY CONTROLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY CONTROLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TRAINING, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TRAINING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY VISCOELASTIC TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY VISCOELASTIC TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY VISCOELASTIC TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SCREENING, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SCREENING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY HEMOPHILIA A, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY HEMOPHILIA A, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY HEMOPHILIA A, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY HEMOPHILIA B, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY HEMOPHILIA B, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY HEMOPHILIA B, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY VON WILLEBRAND DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY VON WILLEBRAND DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY VON WILLEBRAND DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 116. EUROPE BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. EUROPE BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 118. EUROPE BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 119. EUROPE BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 120. EUROPE BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 121. EUROPE BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 122. EUROPE BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 123. EUROPE BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. EUROPE BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. MIDDLE EAST BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 134. AFRICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. AFRICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 136. AFRICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 137. AFRICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 138. AFRICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 139. AFRICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 140. AFRICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 141. AFRICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. AFRICA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. ASEAN BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. ASEAN BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 155. ASEAN BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 156. ASEAN BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 157. ASEAN BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 158. ASEAN BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 159. ASEAN BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. ASEAN BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 161. ASEAN BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 162. GCC BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GCC BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. GCC BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 165. GCC BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 166. GCC BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 167. GCC BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 168. GCC BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. GCC BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. GCC BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 180. BRICS BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. BRICS BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 182. BRICS BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 183. BRICS BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 184. BRICS BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 185. BRICS BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 186. BRICS BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 187. BRICS BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. BRICS BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 189. G7 BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. G7 BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. G7 BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 192. G7 BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 193. G7 BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 194. G7 BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 195. G7 BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 196. G7 BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 197. G7 BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 198. NATO BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. NATO BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. NATO BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 201. NATO BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 202. NATO BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 203. NATO BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 204. NATO BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 205. NATO BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. NATO BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. UNITED STATES BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 209. UNITED STATES BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 210. UNITED STATES BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 211. UNITED STATES BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 212. UNITED STATES BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 213. UNITED STATES BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 214. UNITED STATES BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 215. UNITED STATES BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 216. UNITED STATES BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)
TABLE 217. CHINA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 218. CHINA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 219. CHINA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
TABLE 220. CHINA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2032 (USD MILLION)
TABLE 221. CHINA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
TABLE 222. CHINA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 223. CHINA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. CHINA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 225. CHINA BLEEDING DISORDER DIAGNOSTICS MARKET SIZE, BY DISEASE TYPE, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Bleeding Disorder Diagnostics market report include:
  • Abbott Laboratories
  • ARUP Laboratories
  • Baxter International Inc.
  • Bayer AG
  • Bio-Rad Laboratories, Inc.
  • Cepheid by Danaher Corporation
  • CSL Limited
  • Danaher Corporation
  • Diagnostica Stago SAS
  • F. Hoffmann-La Roche AG
  • HORIBA, Ltd.
  • Hyphen BioMed by Sysmex Corporation
  • Laboratory Corporation of America Holdings
  • Novo Nordisk A/S
  • Ortho Clinical Diagnostics Inc.
  • Precision BioLogic
  • rHEALTH
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific Inc.
  • Werfen Life S.L.U.

Table Information

Report AttributeDetails
No. of Pages180
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 825.34 Million
Forecasted Market Value ( USD ) by 2032 $ 1300 Million
Compound Annual Growth Rate7.9%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Bleeding Disorder Testing Market Report 2025 - Product Image

Bleeding Disorder Testing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Bleeding Disorders Treatment Market Report and Forecast 2025-2034 - Product Image

Bleeding Disorders Treatment Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Bleeding Disorders Treatment Market - Global Forecast 2026-2032 - Product Image

Bleeding Disorders Treatment Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Bleeding Disorders Treatment Market Report 2025 - Product Image

Bleeding Disorders Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Bleeding Disorders Treatment - Global Strategic Business Report - Product Image

Bleeding Disorders Treatment - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.